Hassan Rizk

Dedicated clinical research professional with extensive experience as a clinical research coordinator. Proven adeptness in adhering to study protocols, standard operating procedures, and good clinical practices, ensuring rigorous compliance throughout all phases of research projects. Known for strong problem-solving skills and meticulous attention to detail, facilitating smooth operations and accurate documentation.

• Enrolled in the SHINE trial (Stroke Hyperglycemia Insulin Network Effort), in which we assess whether tight glucose control in stroke patients accounts for a good neurological outcome. It is a Phase III multi-centered, randomized, controlled trial.
• Enrolled in the POINT trial (Platelet-Oriented Inhibition in New TIA and minor ischemic stroke), in which we assess whether aspirin and Plavix will prevent the recurrence of a stroke after a TIA. It is a randomized, double-blind, multi􏰀centered clinical trial.
• Enrolled in the RELAX-AHF Trial which was "A multi-center, randomized, double-blind, placebo-controlled phase IIIb study to evaluate the efficacy, safety and tolerability of SERELAXIN when added to standard therapy in Acute Heart Failure Patients"
• Enrolled patients in the ICON-RELOADED trial (International Collaborative of NT-proBNP re-evaluation of acute diagnostic cut-offs in the emergency department), in which we assess the etiology of shortness of breath by measuring various levels of biomarkers released during an acute episode.
• Enrolled in VALIDATION OF POINT-OF-CARE TBI DETECTION SYSTEM FOR HEAD INJURED PATIENTS (B- AHEAD III Trial) Enrolled in A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SARS-CoV-2 Neutralizing Antibody BGB-DXP593 in Patients With Mild to Moderate COVID-19
• Enrolled in J2W-MC-PYAB a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Patients With Mild to Moderate COVID-19 illness
• Enrolled in J2W-MC-PYAH a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of Mono and combination Therapy and Monoclonal Antibody in participants with Mild to Moderate COVID- 19 illness (BLAZE-4)
• Enrolled in CTAP101-CL-2014 A Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Safety and Efficacy of Rayaldee (calcifediol) Extended-release Capsules to Treat Symptomatic Patients Infected with SARS-CoV- 2 (REsCue)
• Coordinated the National institutes of Health (NIH) – ACTIV-2/A5401
• Coordinated Partner Therapeutics, Inc. – PTX-001-003
• Coordinated ALRN-6924-1-03 A Phase 1b/2 Study of the Dual MDMX/MDM2 Inhibitor, ALRN-6924, for the Prevention of Chemotherapy-induced Myelosuppression
• Coordinated A Randomized, Prospective, Multi-center Trial to Assess the Efficacy of a Cryotherapy Device Versus Best Supportive Oral Care in Mitigating Symptoms of Oral Mucositis in Patients Receiving Chemotherapy for the Treatment of Cancer
• Suzhou Connect Biopharmaceuticals Ltd. - CBP-201-WW002 / 256558, A Multi-center, Randomized, Double-blind, Parallel Group, Placebo-controlled, Efficacy and Safety Study of CBP-201 in Patients with Moderate to Severe Persistent Asthma with Type 2 Inflammation
• Genentech, Inc. - GB43311, A Phase IIb, Randomized, Double-blind, Placebo-Controlled, Multicenter study to evaluate the efficacy and safety of Astegolimab in patients with chronic obstructive pulmonary disease.
• Sanofi- A Randomized, Double-Blind, Placebo controlled Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Patients with Uncontrolled Moderate to Severe Asthma
• A Phase 2, Double-blind, Randomized, Placebo-controlled, Parallel-group, Study to Evaluate the Efficacy and Safety of LX9211 in the Treatment of Patients with Postherpetic Neuralgia (RELIEF-PHN1) LX9211.1-202-PHN

1. Katee Dawood, BS, Bethany Foster, MPH, Jonathon Ottolini, Daniel Foley, Hassan Rizk, Maxwell Wheaton, Revelle Gappy, & Phillip Levy, MD, MPH. May Measurement in Detroit- A Global Campaign to Raise Awareness for Blood Pressure Control.

2. Dawood K, Foster B, Ottolini J, Foley D, Rizk H, Wheaton M, Gappy R, Levy P. May Measurement Month in Detroit􏰀A global campaign to raise awareness for blood pressure control. 2018 Global Health and Innovation Conference; New Haven, CT. April 2018

BLS Certification, ACLS Certification, Michigan certified HIV Test Counselor, Human Subjects Research - Biomedical Investigators, Human Subjects Research - Social & Behavioral Researchers, CITI Good Clinical Practice Course, 09/03/2023, CITI Health Information Privacy and Security (HIPS), Responsible Conduct of Research - Social and Behavioral , CITI Conflicts of Interest - 03/28/2024, Environmental Health & Safety Biological Substances , Shipping and Transport of Regulated Biological Materials

Val Mika, Wayne State University, vmika@med.wayne.edu
Katee Dawood, Wayne State University, kdawood@wayne.edu